Tokyo - Delayed Quote JPY

Roland Corporation (7944.T)

3,175.00

+5.00

+(0.16%)

At close: April 25 at 3:30:00 PM GMT+9

Bitcoin extends rally, AbbVie earnings beat, Phillips 66 miss

As part of today's Market Minute, Julie Hyman examines some of the top stories investors are watching. Bitcoin (BTC-USD) climbs above the $95,000 mark as investors weigh macroeconomic uncertainties. AbbVie (ABBV) stock gains after reporting strong first quarter results and lifting its 2025 profit forecast. Phillips 66 (PSX) shares fall after announcing a wider-than-expected loss in the first quarter. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

Yahoo Finance Video 22 hours ago

ABBV

PSX

BTC-USD
Q1 2025 Sensient Technologies Corp Earnings Call

Q1 2025 Sensient Technologies Corp Earnings Call

Thomson Reuters StreetEvents 6 hours ago

SXT
4 Pipeline Stocks to Buy With $1,000 and Hold Forever

Pipeline companies remain well positioned despite the current disruption in the energy markets. At the same time, demand for natural gas is growing. This is coming from the increased power consumption stemming from artificial intelligence (AI), as well as from export demand from Mexico and for LNG (liquified natural gas) to Asia and Europe.

Motley Fool 6 hours ago

ET

KMI

EPD
Up 12% This Year, Is Berkshire Hathaway Still a Buy?

While most of the U.S. stock market has struggled so far in 2025, Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) has been heading in the opposite, more positive, direction. Of the seven American companies with at least a trillion-dollar market cap, Berkshire Hathaway is the only one up in 2025. Led by Warren Buffett, Berkshire Hathaway's success against the struggles of the broader stock market seems right on course.

Motley Fool 6 hours ago

BRK-B
Sensient Technologies Corp (SXT) Q1 2025 Earnings Call Highlights: Strong Growth Driven by ...

Sensient Technologies Corp (SXT) reports robust revenue and profit growth in Q1 2025, fueled by strategic investments in natural color solutions and overcoming tariff challenges.

GuruFocus.com 8 hours ago

SXT
Galloway Capital builds 3% WW stake, pushes for debt deal amid bankruptcy rumors

Investing.com – Galloway Capital Partners is urging WW International Inc (NASDAQ:WW) to avoid Chapter 11 bankruptcy, after disclosing a 2.87% stake in the embattled weight management company. The firm’s Chief Investment Officer, Bruce Galloway, told Investing.com that Weight Watchers still has solid fundamentals and does not meet the criteria for insolvency, making a bankruptcy filing both unwarranted and damaging to equity holders.

Investing.com 16 hours ago

WW

RGS
Medical Properties (MPW) Stock Declines While Market Improves: Some Information for Investors

In the closing of the recent trading day, Medical Properties (MPW) stood at $5.42, denoting a -0.73% change from the preceding trading day.

Zacks 17 hours ago

MPW
Warren Buffett Is Still at the Top of His Game at 94. Berkshire Hathaway Faces a Future Without Him.

Questions about succession will be front and center when shareholders convene May 3 in Omaha for the company’s annual meeting.

Barrons.com 18 hours ago

BRK-B

^GSPC
Why Biotech Stars Summit Therapeutics and BioNTech Plunged, Even as This Chinese Rival Surged Today

Both U.S.-based Summit Therapeutics (NASDAQ: SMMT) and BioNTech (NASDAQ: BNTX) were down significantly, plunging 36.1% and 15.4%, respectively, in Friday's trading. The severe moves were likely related to a Chinese rival in the PD-1/VEGF bispecific antibody area, Akeso (OTC: AKES.F), receiving FDA approval for a cancer drug that utilizes similar technology, as well as an additional approval in China. As a result, Akeso shares were up 11.7% on Friday.

Motley Fool 18 hours ago

SMMT

BNTX

AKESF
Spotify Stock Tests Buy Point Ahead Of Q1 Report

Spotify stock has been climbing ahead of the streaming music giant's first-quarter report due next Tuesday as investors expect melodious news.

Investor's Business Daily 18 hours ago

SPOT
Sector Update: Consumer Stocks Mixed Late Afternoon

Consumer stocks were mixed late Friday afternoon with the Consumer Staples Select Sector SPDR Fund (

PREMIUM
MT Newswires 19 hours ago

SPOT
FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot

The additional step, which could cost millions of dollars, goes beyond what other Covid-19 vaccine makers had to do to win approval.

The Wall Street Journal 20 hours ago

NVAX
IVV, VOO Help Global ETF Inflows Reach New Heights in Q1

- ETFs attracted $463.5 billion during Q1, surpassing previous records, according to ETFGI. - Equity ETFs led with $211.6 billion in inflows despite the S&P 500's March decline. - Active ETFs gathered $145.3 billion, double last year's first-quarter figure.

etf.com 20 hours ago

IVV

VFFSX

VFIAX
Interim Overall Survival Analysis Requested from Chinese Health Authorities Shows a Clinically Meaningful, Positive Trend Favoring Ivonescimab Compared to Pembrolizumab in PD-L1 Positive Advanced NSCLC from HARMONi-2 Study Conducted by Akeso in China

MIAMI, April 25, 2025--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today noted that Akeso, Inc. (Akeso, HKEX Code: 9926.HK) announced that ivonescimab was approved by the Chinese Health Authorities, the National Medical Products Administration (NMPA), for a second indication based on the results of the Phase III clinical trial, HARMONi-2 or AK112-303. HARMONi-2 evaluated monotherapy ivonescimab against monotherapy pembrolizumab in patients with locally advanced or

Business Wire 20 hours ago

SMMT
Market Chatter: Spotify Technology to Increase Subscription Prices in Europe, Latin America

Spotify Technology (SPOT) will increase subscription prices by 1 Euro ($1.14) on individual subscrip

PREMIUM
MT Newswires 20 hours ago

SPOT
Novavax (NasdaqGS:NVAX) Announces Positive SHIELD-Utah Study Results

Novavax (NasdaqGS:NVAX) recently announced preliminary results from its SHIELD-Utah study, showcasing the Novavax COVID-19 vaccine's effectiveness and reduced side effects compared to a competitor's vaccine. This positive announcement aligns with a 17.8% increase in the company's share price last week. The broader market was also on an upward trend, with indices gaining noticeably over the same period. While the details from Novavax's study can potentially bolster investor confidence and...

Simply Wall St. 21 hours ago

NVAX
Eni Beats on Q1 Earnings & Revenues, Lowers '25 Capex Guidance

Higher natural gas price realizations aid E's Q1 earnings.

Zacks 21 hours ago

ENI.MI

KMI

AROC
Phillips 66 Posts Wider-Than-Expected Q1 Loss on Lower Refining Volumes

Lower realized refining margins worldwide hurt PSX Q1 earnings.

Zacks 22 hours ago

PSX

AROC

KMI
Should You Buy Spotify Stock Ahead of Q1 Earnings Report?

SPOT's first-quarter 2025 earnings and revenues are likely to increase year over year.

Zacks 22 hours ago

SPOT
Warren Buffett Stocks: What's Inside Berkshire Hathaway's Portfolio?

You must keep up on Warren Buffett stocks: The Berkshire Hathaway chief sticks to a winning investing formula, but he does not sit still.

Investor's Business Daily 23 hours ago

BRK-A

AAPL

Performance Overview

Return	7944.T	Nikkei 225 (^N225)
YTD	-19.01%	-10.50%
1-Year	-21.79%	-5.11%
3-Year	-19.76%	+34.28%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Roland Corporation (7944.T)

Related News

Bitcoin extends rally, AbbVie earnings beat, Phillips 66 miss

Q1 2025 Sensient Technologies Corp Earnings Call

4 Pipeline Stocks to Buy With $1,000 and Hold Forever

Up 12% This Year, Is Berkshire Hathaway Still a Buy?

Sensient Technologies Corp (SXT) Q1 2025 Earnings Call Highlights: Strong Growth Driven by ...

Galloway Capital builds 3% WW stake, pushes for debt deal amid bankruptcy rumors

Medical Properties (MPW) Stock Declines While Market Improves: Some Information for Investors

Warren Buffett Is Still at the Top of His Game at 94. Berkshire Hathaway Faces a Future Without Him.

Why Biotech Stars Summit Therapeutics and BioNTech Plunged, Even as This Chinese Rival Surged Today

Spotify Stock Tests Buy Point Ahead Of Q1 Report

Sector Update: Consumer Stocks Mixed Late Afternoon

FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot

IVV, VOO Help Global ETF Inflows Reach New Heights in Q1

Interim Overall Survival Analysis Requested from Chinese Health Authorities Shows a Clinically Meaningful, Positive Trend Favoring Ivonescimab Compared to Pembrolizumab in PD-L1 Positive Advanced NSCLC from HARMONi-2 Study Conducted by Akeso in China

Market Chatter: Spotify Technology to Increase Subscription Prices in Europe, Latin America

Novavax (NasdaqGS:NVAX) Announces Positive SHIELD-Utah Study Results

Eni Beats on Q1 Earnings & Revenues, Lowers '25 Capex Guidance

Phillips 66 Posts Wider-Than-Expected Q1 Loss on Lower Refining Volumes

Should You Buy Spotify Stock Ahead of Q1 Earnings Report?

Warren Buffett Stocks: What's Inside Berkshire Hathaway's Portfolio?

Performance Overview